Copiktra is a prescription medication that is used to treat certain types of blood cancers, specifically chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It is also indicated for the treatment of follicular lymphoma in patients who have received at least two prior systemic therapies.

The active ingredients in Copiktra are duvelisib, which works by targeting specific enzymes in the body that are involved in the growth and survival of cancer cells. By inhibiting these enzymes, Copiktra helps to slow down the progression of the cancer and may even lead to remission in some cases.

It is important to follow your healthcare provider’s instructions when taking Copiktra, as the dosage and frequency of administration will vary depending on your specific condition and medical history. It is typically taken orally, with or without food, and should not be crushed, chewed, or broken.

Like all medications, Copiktra may cause side effects in some patients. Common side effects include diarrhea, nausea, fatigue, and respiratory infections. It is important to report any side effects to your healthcare provider, as they may be able to adjust your dosage or recommend other treatments to help manage them.

Before starting treatment with Copiktra, be sure to inform your healthcare provider about any other medications or supplements you are taking, as they may interact with Copiktra and cause unwanted side effects. It is also important to discuss any pre-existing medical conditions you have, as they may affect your ability to take Copiktra safely.

Overall, Copiktra is an important treatment option for patients with certain types of blood cancers, and when taken as directed, it can help to improve outcomes and quality of life.